Full name
PRZEDSIĘBIORSTWO FARMACEUTYCZNE "APEXIM" SPÓŁKA AKCYJNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 6,3 | 8,3 | 7,8 | -5,7 |
EBITDA | 2 | 4 | 2,7 | -32,4 |
Short time liabilities | 15,6 | 16,3 | 19 | 16,5 |
Equity capital | 61,8 | 69 | 75,9 | 9,9 |
Operating profit (EBIT) | 1,6 | 3,4 | 2,1 | -38,6 |
Assets | 78 | 86,5 | 96,3 | 11,3 |
Net profit (loss) | 5,8 | 7,2 | 6,9 | -4,4 |
Cash | 0,3 | 0,6 | 0,7 | 31,5 |
Net income from sale | 76,5 | 92,1 | 103,4 | 12,3 |
Liabilities and provisions for liabilities | 16,2 | 17,4 | 20,4 | 16,9 |
Working assets | 33,4 | 39,8 | 49 | 23 |
Depreciation | 0,5 | 0,6 | 0,6 | 2,3 |
% | % | % | p.p. | |
Profitability of capital | 9,4 | 10,4 | 9 | -1,4 |
Equity capital to total assets | 79,3 | 79,8 | 78,8 | -1 |
Gross profit margin | 8,2 | 9 | 7,5 | -1,5 |
EBITDA Margin | 2,6 | 4,4 | 2,6 | -1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 75 | 65 | 67 | 2 |
Current financial liquidity indicator | 2.11124324798584 | 2.3707780838012695 | 2.4750499725341797 | 0,1 |
Net dept to EBITDA | -0.12354891747236252 | -0.10518784075975418 | -0.23161518573760986 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane